ESC Premium Access

LDL-Cholesterol lowering at a turning point

Event: EuroPRevent Meeting 2016
Topic: Lipids
Session type: Symposium
Date: 15 June 2016
Time: 09:00 - 10:30


4 presentations in this session

2016 update on LDL as a risk factor.

Speaker: Professor L. Tokgozoglu (Ankara, TR)

Status of CVD Health and cholesterol in Europe

Speaker: Doctor S. Sans Menendez (Barcelona, ES)

PCSK9 inhibition: The new player in the field.

Speaker: Professor D. Ural (Istanbul, TR)

The future of LDL lowering Recent data from PCSK9 inhibitors and outlook for upcoming trials.

Speaker: Professor U. Landmesser (Berlin, DE)

4 speakers from this session

Professor Lale Tokgozoglu

Hacettepe University, Ankara (Turkey)
23 presentations
0 follower

Doctor Susana Sans Menendez

Department of Health, Barcelona (Spain)
1 presentation
0 follower

Professor Dilek Ural

Koc University School of Medicine, Istanbul (Turkey)
3 presentations
0 follower

Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)
34 presentations
1 follower

This platform is supported by

logo Novo Nordisk